Hong Kong stocks intraday | The three major indices fluctuated narrowly, the innovative drug sector strengthened significantly, and Kuaishou clarified the rumors of a spin-off and performed actively

Market Pulse
2026.05.12 06:33
portai
I'm LongbridgeAI, I can summarize articles.

On the afternoon of May 12, the Hong Kong stock market continued its narrow fluctuation pattern, with the Hang Seng Tech Index's decline expanding. Structural opportunities in the market became prominent: Hengrui Pharma and Bristol Myers Squibb (BMS) reached a global strategic cooperation worth over $10 billion, driving the innovative drug sector to surge against the market trend; Kuaishou clarified that the spin-off of Kuaishou AI is still in the preliminary evaluation stage, with its stock price continuing to strengthen and ranking among the top in trading volume. Meanwhile, the semiconductor sector was dragged down by overseas market sentiment, while resource stocks performed actively against the backdrop of rising international oil prices